Generics North America (NAFTA) Industry Guide_2017
The NAFTA Generics industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Essential resource for top-line data and analysis covering the NAFTA generics market. Includes market size and segmentation data, textual and graphical analysis of market growth trends and leading companies.
The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The generics industry within the NAFTA countries had a total market value of $110.2 billion in 2016.The Mexico was the fastest growing country, with a CAGR of 13.7% over the 2012-16 period.
Within the generics industry, the US is the leading country among the NAFTA bloc, with market revenues of $99.7 billion in 2016. This was followed by Mexico and Canada, with a value of $6.3 and $4.2 billion, respectively.
The US is expected to lead the generics industry in the NAFTA bloc, with a value of $141.2 billion in 2021, followed by Mexico and Canada with expected values of $10.1 and $4.9 billion, respectively.
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the NAFTA generics market
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the NAFTA generics market
Leading company profiles reveal details of key generics market players’ NAFTA operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the NAFTA generics market with five year forecasts by both value and volume
Compares data from the US, Canada and Mexico, alongside individual chapters on each country
Reasons to buy
What was the size of the NAFTA generics market by value in 2016?
What will be the size of the NAFTA generics market in 2021?
What factors are affecting the strength of competition in the NAFTA generics market?
How has the market performed over the last five years?
Who are the top competitors in the NAFTA generics market?